Lung Health Related News
Therapeutic target identified to treat chronic obstructive pulmonary disease
New hope has emerged for people with the debilitating and often deadly chronic obstructive pulmonary disease, with scientists discovering a new therapeutic target that...
MonitAir: Empowering patients to monitor their symptoms of COPD
MonitAir is a cutting-edge eHealth product that enables patients to monitor their symptoms of COPD accurately, providing them with unprecedented insights into their condition...
Identifying the scent of a failing lung transplant with innovative eNose
Researchers based in the Netherlands have developed a revolutionary electronic “nose” that is proficient in smelling out when a lung transplant is starting to...
AI blood testing technology developed to detect lung cancers
Researchers have developed an artificial intelligence (AI) blood test technology to detect lung cancers with high accuracy.
A research team from Johns Hopkins Kimmel Cancer...
Lung disease drug offers hope for heart failure patients
A drug currently used to treat lung fibrosis could be repurposed to treat heart failure patients, an early phase trial has suggested.
Doctors and scientists...
Discovery could inform new preventative treatment for blood clots
A breakthrough in the understanding of why blood clots form in the lungs could lead to improvements in preventative treatment.
Researchers from the University of...
New findings could help to protect lungs from tuberculosis
Scientists have discovered new insights on tuberculosis, which could lead to new drug treatments to speed up recovery.
Two new studies from the University of...
Researchers discover potential new way of fighting TB
A team of researchers believe they may have uncovered a new method of fighting tuberculosis (TB) – by starving it of a certain sugar.
TB...
Exploring innovation in lung health during COVID-19
Dr Andy Whittamore, Clinical Lead at Asthma UK and the British Lung Foundation, tells HEQ about developments in the treatment of lung conditions.
Dr Andy...
Protecting health from radon exposure
A new survey from the World Health Organization has highlighted that countries still need to take action to mitigate the impacts of radon exposure.
In...
Advancing understanding of TB and respiratory infections with lung-on-chip
An innovative ‘lung-on-chip’ is providing new insights into the body’s response to early tuberculosis infection and could provide a model for future research into...
Harnessing the power of sound waves for advances in drug delivery
Pioneering new research is harnessing the power of sound waves to deliver drugs – demonstrating how high-frequency sound could revolutionise the field of ultrasound-driven...
Potential new medicine shows promise for patients with severe asthma
AstraZeneca and Amgen have announced positive results from the NAVIGATOR Phase III trial for a potential new medicine that could help patients with severe,...
CBD reduces COVID-19 lung damage with protective peptides
In a new study, scientists have shown that one of the non-psychoactive cannabinoids in cannabis – CBD – reduces lung damage induced by cytokine...
Five factors influencing the respiratory disease testing market
Respiratory disease testing market growth will be driven by the growing prevalence of respiratory diseases such as tuberculosis, asthma, chronic obstructive pulmonary disease, and...
Cystic fibrosis: searching for a cure
The Cystic Fibrosis Foundation aims to deliver treatment, care and – eventually – a cure for CF.
Cystic fibrosis (CF), which affects more than 70,000...
Fighting for a life unlimited with the Cystic Fibrosis Trust
Dr Lucy Allen, Director of Research at the Cystic Fibrosis Trust, speaks with HEQ about cystic fibrosis research, treatment and innovation.
Founded in 1964, the...
Three new diagnostic kits launched for COVID-19 and respiratory illnesses
Three new diagnostic kits have been launched to help with the diagnosis of COVID-19 and other respiratory illnesses.
BATM, a leading provider of real-time technologies...
Study shows triple-combination therapy reduces COPD exacerbations
Results from a Phase III trial have shown how a triple-combination therapy reduces the rate of moderate or severe COPD exacerbations.
The results from the...
Could the brain be a therapeutic target for COVID-19 patients?
A new study in rats has revealed that the brain could be a potential therapeutic target for COVID-19 patients.
New research, published today in The Journal...
